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Abstract Sol–gel encapsulation has been used as the
basis for detecting cortisol by an immunoassay approach.
Previous research showed that antibodies immobilized in
the pores of a sol–gel derived silica were able to bind
cortisol and be used as an immunosensor. However, this
approach was not effective when measuring cortisol levels
in human serum because of interference from other fluo-
rescence sources. The present paper describes a protocol
which overcomes these limitations and enables sol–gel
immunoassays to effectively measure cortisol in human
serum over the physiological range of cortisol blood con-
centrations in an adult (2–28 lg/dL). The method involves
a standard additions approach in which various amounts of
cortisol are added to the serum. The cortisol concentration
values obtained with our sol–gel immunoassay were typi-
cally within 10% of the values obtained by traditional
analytical methods. The protocol presented here represents
a significant contribution to sol–gel sensing and immuno-
assays in particular, because of the ability to detect an
analyte in human serum. In addition, this work reports the
first comparison between results from a sol–gel immuno-
sensor and an alternative immuno-binding method for
analyte detection.
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1 Introduction
The sol–gel process is a low-temperature method for syn-
thesizing inorganic glass at room temperature. The
chemistry is based on the hydrolysis and condensation of
molecular precursors such as metal alkoxides [1–4]. The
sol, a stable suspension of colloidal solid particles in a
liquid, undergoes gelation which leads to the formation of a
porous 3-dimensional interconnected matrix with an
interstitial liquid phase [5]. The sol–gel process has been
the subject of numerous studies and the ability to fabricate
various oxides into optically transparent monoliths, films,
as well as fibers and opaque powders, is well established
[5–9].
During the 1990s researchers realized that sol–gel
methods could be used to immobilize a wide range of
enzymes and other proteins, leading to materials which
exhibit biochemical responses [10–15]. As long as the
biomolecule was soluble in the aqueous or alcohol-based
solvent, it could be incorporated within the pores of the
inorganic matrix, and effectively impart its properties to
the resulting solid [1, 6, 9]. Among the different biomol-
ecule immobilization methods, sol–gel encapsulation has
emerged as one of the most attractive approaches. This
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route has demonstrated a number of advantages including
the preservation of the structure and activity of the bio-
molecule, prevention of self-aggregation, protection from
outside environmental conditions, improved thermal
resistance and storage capability, good mechanical dura-
bility, and good optical properties [14, 16–19]. The latter is
of central importance because of the ability to use the
optical properties of the biomolecule for a variety of sensor
applications. Another key feature associated with sol–gel
based materials is the microstructure of the matrix. The
intrinsic pore size can be tailored such that small analytes
can diffuse in and bind or react with the encapsulated
biomolecule while the larger, encapsulated biomolecule is
unable to diffuse out of the matrix [1, 17]. It is significant
to mention that the field of sol–gel immobilization con-
tinues to be extremely active. The sensor area has grown
considerably through the design of sol–gel materials with
enhanced biorecognition, while the ability to encapsulate
membrane-bound proteins has led to applications in high
throughput drug screening [20, 21].
This paper presents work in another important area, that
of using sol–gel encapsulation as the basis for immunoas-
says. Immunoassays are common techniques for measuring
a wide variety of analytes in standard solutions and in serum
samples. Over the past decade, sol–gel encapsulation of
biomolecules for immunoassays has generated considerable
interest because the encapsulation overcomes some limita-
tions in the technology [17, 22–25]. A problematic issue for
traditional immunoassays, such as enzyme-linked immu-
nosorbent assays (ELISA), is that certain biomolecules,
such as proteins, lose their stability or functionality upon
immobilization [17]. Common immobilization techniques,
such as physical adsorption and covalent bonding [17] have
well known limitations. Physical adsorption of the bio-
molecule to the surface utilizes weak bonding. In contrast,
covalent bonding provides a strong attachment of the bio-
molecule to the surface but difficulties arise in isolating the
biomolecule for analysis and detection. In the present paper,
we used sol–gel encapsulation to not only achieve long-
term storage but also to make the analytical protocol com-
patible with on-orbit detection.
The immunoassay of interest in this paper is the hormone
cortisol. Cortisol is a glucocorticoid that regulates metab-
olism and provides resistance to stress in the body [26]. The
physiological range of cortisol blood concentrations in an
adult is 2–28 lg/dL. High levels of cortisol indicate a high
amount of stress and lead to a significant reduction in the
immune response. For this reason, cortisol is of interest to
NASA because it can serve as a biomarker for the health of
the astronaut crew. On-orbit monitoring is particularly
important for prolonged space missions as the microgravity
environment of space places additional stress, physically
and psychologically, on humans during these missions [27].
Traditional methods developed for the detection of bio-
molecules such as cortisol involve radioimmunoassays
(RIA) and enzyme-linked immunosorbent assays (ELISA)
[28–31]. However, these methods are not viable for use on-
orbit because of concerns over radioactivity (RIA) and
multiple liquid handling steps (ELISA). As a result, the
measurement of hormones and other biomolecules occurs
on earth, i.e., only before and after space flights.
The present paper builds upon our prior work in which
we demonstrated a sol–gel immunoassay for cortisol. In
that work, we showed that antibodies immobilized in the
pores of the sol–gel derived silica were able to bind cor-
tisol. We also demonstrated that the sol–gel immunoassay
was able to measure cortisol over a physiologically rele-
vant range and that only one washing was required in the
analysis. This last point is of considerable importance for
on-orbit applications. However, when we went to use this
approach to measure cortisol levels in human serum, we
experienced a number of difficulties related to background
fluorescence from the presence of other biomolecules in
serum as well as non-specific binding. We overcame these
problems by developing a measurement protocol based on
the ‘‘standard additions’’ technique. Our experimental
results are in excellent agreement with measurements made
by a standard immunoassay method. The results reported
here are among the first sol–gel immunoassays to be
compared directly to standard analytical methods and
represent the first report of using a sol–gel based assay
method to monitor an analyte present in human serum.
2 Background
Sol–gel immunoassays for cortisol were used to measure
cortisol in the physiological relevant range of
1–100 lg dL-1. A competitive immunoassay approach
was used based on doping anti-cortisol in a silica sol in
which the resulting sol–gel matrix was designed to have an
average pore diameter of approximately the same size as
the antibody. Figure 1 shows typical calibration curves
from these sol–gel immunoassays [22]. The fluorescence
decrease with the logarithmic increase in unlabeled cortisol
is expected for competitive immunoassays [32–34]. Fig-
ure 1a presents the experimentally obtained fluorescence
data while in Fig. 1b the fluorescence intensity has been
normalized according to the standard approach for ana-
lyzing competitive immunoassays. In addition to the
monolithic samples shown here, competitive immunoassay
experiments were also carried out using sol–gel thin films
which immobilized anti-cortisol. These materials exhibited
an analogous response to that shown in Fig. 1. An advan-
tage of using thin films is that it reduces the required assay
time substantially.
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Unfortunately, sol–gel competitive immunoassays were
unable to detect cortisol levels accurately when human
serum samples were used. Figure 2 compares sol–gel
immunoassay results obtained from standard cortisol
solutions with results obtained for a few serum samples.
The latter were supplied by the NASA Johnson Space
Center (NASA-JSC). There is a significant discrepancy
between the cortisol concentrations from NASA-JSC,
analyzed by standard immunoassay methods, and those
obtained from our sol–gel immunoassays (Table 1). We
hypothesize that luminescence from other biomolecules
present in serum may interfere with the fluorescence signal
coming from the labeled cortisol used in the sol–gel
immunoassays. The background intensity may come from
the luminescence of other biomolecules that could cova-
lently bind to the hydrophilic silica matrix. Serum contains
intrinsic fluors, or biomolecules that are naturally fluores-
cent, such as proteins containing amino acids with phenyl
rings [35]. The emission from these fluors could interfere
with that coming from the labeled cortisol, thus masking
the signal. To resolve these problems, we developed a
protocol which enabled us to obtain accurate detection of
cortisol levels in human serum.
3 Experimental details
3.1 Materials
Tetramethylorthosilicate (TMOS) and hydrocortisone
(cortisol) were purchased from Sigma-Aldrich Chemical
Co. Phosphate buffer saline solution (1X PBS), sodium
phosphate buffer, methanol, and hydrochloric acid were
obtained from Fisher Scientific. Monoclonal cortisol anti-
body (Lot #L28, density = 2.14 mg/mL) was purchased
from East Coast Biologics. Human serum samples were
supplied by the NASA-JSC. Oregon Green conjugated to
cortisol (OG-cortisol) was purchased from Molecular
Probes, Inc.
Fluorescence measurements were made with a Fluoros-
kan Ascent Type 374 fluorimeter from ThermoLabsystems.
Fig. 1 a Fluorescence signal versus the logarithm of the unlabeled
cortisol concentration for sol–gel competitive immunoassays using
silica monoliths containing 0.16 lM anti-cortisol antibody. b Fluo-
rescence is converted to normalized intensity B/B0 (reprinted with


















Fig. 2 Fluorescence versus unlabeled cortisol concentration for
standard cortisol solutions (calibration curve) and some serum
samples (JSC3, JSC5, JSC6). The unlabeled cortisol concentrations
for the serum samples are values obtained from NASA-JSC
Table 1 Comparison of cortisol concentration values reported by







JSC3 27.7 4.4 ± 1.7
JSC5 16.3 3.2 ± 0.5
JSC6 11.2 1.0 ± 0.2
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A Dayton DC Speed Control was used to control the
velocity of the dip-coating machine. The Immulite 2000
analyzer from Diagnostic Products Corporation was used by
NASA-JSC to determine the cortisol concentration levels of
the serum samples.
3.2 Preparation of antibody doped sol–gel thin films
The sol was prepared by combining 4 mL of TMOS,
0.9 mL of DI water, and 0.2 mL of 0.02 N HCl and soni-
cating the solution for 30 min [22]. After sonication,
methanol was added to the hydrolyzed sol and filtered with
a 0.2 lm syringe filter [22]. Two hundred and thirty micro
liters of the monoclonal antibody to cortisol (den-
sity = 2.14 mg/mL) was added to 7.15 mL of 5 mM
sodium phosphate buffer solution with pH 6.0. The buf-
fered antibody solution was then added to 5.85 mL of the
sol/methanol mixture. After 15 min, thin films were dip-
coated on to clean glass cover slips. The thin films on the
cover slips were then allowed to dry in air for 100 s before
being stored in 1X PBS in a refrigerator for later use.
3.3 Competitive immunoassays for cortisol
Figure 3 illustrates the specific details of the approach used
for sol–gel competitive immunoassays. In a typical com-
petitive immunoassay, both fluorescently labeled cortisol
(conjugated with Oregon Green) and unlabeled cortisol
from serum bind competitively to the sol–gel encapsulated
antibody [36]. Fluorescence is detected from the labeled
cortisol and can be correlated with the concentration of
unlabeled cortisol from serum. A higher fluorescent signal
is indicative of a lower analyte concentration since more of
the labeled analyte is bound to the antibody. For the cor-
tisol immunoassay, an assay mixture of 1.2 mL of 1X PBS,
1.5 lL of 20 lM OG-cortisol, and 50 lL of the treated
serum sample was added to a cuvette. The antibody-doped
sol–gel thin films were then added to the cuvette and the
assay mixture was incubated on a rotator for 20 min. The
thin films were then rinsed with deionized water and placed
over individual wells in a 96-well plate. Fluorescence
measurements were taken in triplicate with the excitation
and emission wavelengths being 485 and 538 nm,
respectively.
4 Results and discussion
4.1 Standard additions procedure and analysis
The standard additions method has been widely used to
detect a variety of analytes in complex media, such as
biological fluids, where interference in analyte signal can
cause inaccuracies [37–42]. The method used here is
similar to the Gran plot standard additions method used
previously to determine unknown parameters, such as the
slope and y-intercept of a calibration curve for the detec-
tion and monitoring of ions [43–46]. The Gran plot
standard addition technique also eliminates the need for
reference calibration curves [46]. A diagram depicting the
method of standard additions is shown in Fig. 4. A human
serum sample of unknown cortisol concentration was
divided equally into three tubes. Then, equal volumes of
different cortisol concentrations were added to each tube.
Treated serum samples #1, 2, and 3 all came from one
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Fig. 3 Procedure for sol–gel
competitive immunoassays
using both thin film and bulk
monolithic materials
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The protocol involves taking 600 lL of a human serum
sample of unknown cortisol concentration, c, and dividing
it into three microcentrifuge tubes with 200 lL of serum in
each tube. Then, 6.9 lL of 60 lg/dL of cortisol was added
to the first tube, 6.9 lL of 600 lg/dL of cortisol was added
to the second tube, and 6.9 lL of 1,800 lg/dL of cortisol
was added to the last tube. The volumes and concentrations
for the added cortisol were calculated with the assumption
that the serum sample contained no cortisol. A conven-
tional method for representing data from competitive
immunoassays is shown in Fig. 1, where the fluorescent
intensity is plotted versus the logarithm of the unlabeled
analyte concentration [32]. In our case, this would yield a
linear relationship:
f ¼ m  ln cð Þ þ b ð1Þ
where f is fluorescence intensity, c is the cortisol
concentration, and m and b are the slope and y-intercept
of the line, respectively. Three equations can be written for
each of the three treated serum samples with different final
cortisol concentrations:
f1 ¼ m  ln c þ 2ð Þ þ b ð2Þ
f2 ¼ m  ln c þ 20ð Þ þ b ð3Þ
f3 ¼ m  ln c þ 60ð Þ þ b ð4Þ
where f1, f2, and f3 are the fluorescent intensities obtained
from the competitive immunoassay on serum samples 1, 2,
and 3, respectively. The three unknown variables c, m, and
b can be determined by solving these three simultaneous
Eqs. 2–4. To minimize error, the actual cortisol concen-
tration is 1.03*c.
4.2 Competitive immunoassays on spiked human
serum samples
The standard additions method enabled us to circumvent
the fluorescence interference problem and obtain accurate
values for cortisol in human serum. The results from thin
film sol–gel immunoassays carried out on seven different
‘‘spiked’’ human serum samples (a–g) are shown in Fig. 5,
in which fluorescence is plotted as a function of unlabeled















Fig. 4 Standard additions








































Fig. 5 Fluorescence versus the logarithm of the unlabeled cortisol
concentration of seven ‘‘spiked’’ serum samples: a samples (a–d). b
Samples (e–g). Error bars represent the standard deviations from the
mean values for the data taken in triplicate
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fluorescence and the logarithm of the cortisol concentration
(Eq. 1) was confirmed for these ‘‘spiked’’ serum samples.
The fit of the data was such that the fraction of variance
(R-squared value) was equal to unity and linearity was
maintained for all serum samples. These assays have good
reproducibility as the average standard deviation in inten-
sity for the seven ‘‘spiked’’ serum samples of Fig. 5 was
9.4%. This value is comparable to that of previous sol–gel
thin film immunoassays for cortisol [22].
The analytical procedure outlined in Sect. 3.1 was per-
formed on numerous human serum samples to determine
their cortisol content. The calibration curve parameters m
and b were determined from fitted linear calibration curves
(Eq. 1) with y defined as exp (b/m). The values of these
parameters (y, m, and b) for the seven samples of Fig. 5 are
summarized in Table 2. The slopes of the linear curves (m)
are not constant due to the varying intensities from the
assay. The slopes and y-intercepts of these linear calibra-
tion curves have no apparent physical meaning as they are
just variables used to obtain cortisol levels in the serum.
Since f1, f2, f3, m, and b are all known quantities, the cor-
tisol concentration of each human serum sample was
calculated by substituting these 5 parameters into Eqs. 2–4.
Cortisol concentrations determined from our sol–gel
immunosensor for serum samples a–g are shown in
Table 2.
The cortisol concentration values obtained from our sol–
gel immunosensor were compared with measurements
made by NASA-JSC on the same samples. At NASA-JSC
the instrument used to make cortisol measurements is
based on a technique which involves immuno-binding,
multiple washings of unbound material, and detection of a
chemiluminescent substrate from the assay. The cortisol
concentrations of the serum samples ranged from 4.3 to
17.9 lg/dL.
We are able to successfully correlate the cortisol con-
centration values of the sol–gel immunoassay to within
15% of the values obtained by NASA-JSC. Moreover, for
several samples, there was less than a 5% difference. As
shown in Fig. 6, which directly compares the two
approaches, there is very good correlation between the
cortisol concentration values obtained from NASA-JSC
and our sol–gel immunosensor. The data indicates that
there were very few outliers such as sample e. Our results
are comparable, if not better than previous cortisol sensing
studies in serum in which fluorescence polarization
immunoassays were correlated with radioimmunoassays
[47, 48]. Table 3 shows the results of multiple tests on
various serum samples using the standard additions
method. For this set of samples, NASA-JSC had coefficient
of variances ranging from 6.8 to 9.4% with the chemilu-
minescent method, comparable to the coefficient of
variances obtained with our sol–gel immunosensor using
the standard additions method (Table 3). A final point to
mention is that the total time to perform this measurement
procedure with the thin film immunoassay is approximately
30 min. These results show promise for adapting the
standard additions method for a miniaturized sol–gel
immunoassay system that can be used on-orbit.
Table 2 Calibration curve parameters (y, m, b) and cortisol concen-
trations for ‘‘spiked’’ serum samples a–g
Serum
sample
y m b Calculated cortisol
conc. (lg/dL)
a 3.84e-03 -0.09 0.50 13.7
b 1.75e-03 -0.11 0.68 11.6
c 1.71e-03 -0.07 0.46 12.5
d 6.52e-03 -0.15 0.76 9.20
e 7.83e-03 -0.15 0.74 12.8
f 6.01e-03 -0.10 0.51 8.60
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Fig. 6 Comparison of cortisol concentration values reported by
NASA-JSC (chemiluminescent method) versus values obtained by the
sol–gel immunoassay. The slope of the curve is unity. Results are
shown for multiple human serum samples, including a–g as indicated
Table 3 Cortisol concentration values for various human serum
samples determined by NASA-JSC and by the sol-gel immunosensor
using the method of standard additions (standard deviations from
mean shown). The number of times (n) an individual serum sample
has been analyzed is also shown. Cortisol concentration (lg/dL)
NASA-JSC Our sol–gel immunosensor n
7.6 6.9 ± 1.1 3
7.84 8.9 ± 2.9 3
10.9 9.8 ± 1.6 2
11.1 11.6 ± 1.3 2
13.2 11.4 ± 1.9 4
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5 Conclusions
A competitive immunoassay based on sol–gel encapsula-
tion of antibodies was successfully used for sensing
cortisol. By adopting a standard additions method for
analysis, cortisol was accurately detected in human serum
samples. The cortisol concentration values obtained with
our sol–gel immunoassay were typically within 15% of the
values obtained by traditional analytical methods. The
protocol presented here represents a significant contribu-
tion to sol–gel sensing and immunoassays in particular,
because of the ability to detect an analyte in human serum.
In addition, this work reports the first comparison between
results from a sol–gel immunosensor and an alternative
immuno-binding method for analyte detection. These
results are promising for developing a miniaturized sol–gel
bioassay system for in-flight monitoring of cortisol and
other important biomarkers.
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